|
|
Other links at Articles > Allergy and Clinical Immunology |
| 2. |
FDA Safety Changes: Celexa, Erbitux, ACE Inhibitors
|
|
|
The FDA has approved revisions to the safety labeling for citalopram HBr tablets and oral solution, cetuximab intravenous infusion, and certain angiotensin-converting enzyme inhibitors.
Medscape Medical News
|
|
|